Cargando…
Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages
BACKGROUND: Melanoma has the highest mortality rate among all the types of skin cancer. In melanoma, M2-like tumor-associated macrophages (TAMs) are associated with the invasiveness of tumor cells and a poor prognosis. Hence, the depletion or reduction of M2-TAMs is a therapeutic strategy for the in...
Autores principales: | Jeong, Chanmi, Kim, Jeongdong, Han, Ik-Hwan, Kim, Soyoung, Choi, Ilseob, Kim, Hongsung, Jeong, Jin-Hyun, Bae, Hyunsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140360/ https://www.ncbi.nlm.nih.gov/pubmed/37122692 http://dx.doi.org/10.3389/fimmu.2023.1178776 |
Ejemplares similares
-
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Kim, Soyoung, et al.
Publicado: (2022) -
Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
por: Han, Ik-Hwan, et al.
Publicado: (2022) -
TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Lee, Chanju, et al.
Publicado: (2022) -
Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
por: Lee, Chanju, et al.
Publicado: (2019) -
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis
por: Lee, Chanju, et al.
Publicado: (2022)